Related Experiment Video
Updated: Jul 22, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer
Brooke D Paradise1,2, Vladimir G Gainullin1, Luciana L Almada1
1Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.
Abstract:
Aberrant activation of the Hedgehog (Hh) signaling pathway, through which the GLI family of transcription factors (TF) is stimulated, is commonly observed in cancer cells. One well-established mechanism of this increased activity is through the inactivation of Suppressor of Fused (SUFU), a negative regulator of the Hh pathway. Relief from negative regulation by SUFU facilitates GLI activity and induction of target gene expression. Here, we demonstrate a novel role for SUFU as a promoter of GLI activity in pancreatic ductal adenocarcinoma (PDAC). In non-ciliated PDAC cells unresponsive to Smoothened agonism, SUFU overexpression increases GLI transcriptional activity. Conversely, knockdown (KD) of SUFU reduces the activity of GLI in PDAC cells. Through array PCR analysis of GLI target genes, we identified B-cell lymphoma 2 (BCL2) among the top candidates down-regulated by SUFU KD. We demonstrate that SUFU KD results in reduced PDAC cell viability, and overexpression of BCL2 partially rescues the effect of reduced cell viability by SUFU KD. Further analysis using as a model GLI1, a major TF activator of the GLI family in PDAC cells, shows the interaction of SUFU and GLI1 in the nucleus through previously characterized domains. Chromatin immunoprecipitation (ChIP) assay shows the binding of both SUFU and GLI1 at the promoter of BCL2 in PDAC cells. Finally, we demonstrate that SUFU promotes GLI1 activity without affecting its protein stability. Through our findings, we propose a novel role of SUFU as a positive regulator of GLI1 in PDAC, adding a new mechanism of Hh/GLI signaling pathway regulation in cancer cells.
Insights
Suppressor of Fused (SUFU) surprisingly promotes GLI activity in pancreatic ductal adenocarcinoma (PDAC). SUFU enhances GLI-driven BCL2 expression, impacting cancer cell viability and offering new insights into Hedgehog signaling in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Aberrant activation of the Hedgehog (Hh) signaling pathway, involving GLI transcription factors (TF), is common in cancer.
- Suppressor of Fused (SUFU) typically acts as a negative regulator of the Hh pathway, and its inactivation increases GLI activity.
- Understanding novel regulatory mechanisms of Hh/GLI signaling is crucial for cancer therapy.
Purpose of the Study:
- To investigate the role of SUFU in regulating GLI activity in pancreatic ductal adenocarcinoma (PDAC).
- To identify novel mechanisms of Hh/GLI pathway regulation in cancer cells.
Main Methods:
- SUFU knockdown (KD) and overexpression in PDAC cells.
- Array PCR analysis to identify GLI target genes.
- GLI1-SUFU interaction studies and chromatin immunoprecipitation (ChIP) assays.
- Assessment of cell viability and BCL2 rescue experiments.
Main Results:
- SUFU overexpression increased GLI transcriptional activity in non-ciliated PDAC cells.
- SUFU KD reduced GLI activity and BCL2 expression, leading to decreased PDAC cell viability.
- Overexpression of BCL2 partially rescued the reduced cell viability caused by SUFU KD.
- SUFU and GLI1 interact in the nucleus and bind to the BCL2 promoter, promoting GLI1 activity without affecting protein stability.
Conclusions:
- SUFU acts as a novel promoter of GLI activity in PDAC, challenging its traditional role as solely a negative regulator.
- SUFU positively regulates GLI1-driven BCL2 expression, impacting PDAC cell viability.
- This study reveals a new mechanism of Hh/GLI signaling pathway regulation in cancer cells.

